{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T19:08:23Z","timestamp":1772910503893,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.ygyno.2009.10.079","type":"journal-article","created":{"date-parts":[[2009,12,3]],"date-time":"2009-12-03T09:59:56Z","timestamp":1259834396000},"page":"211-215","source":"Crossref","is-referenced-by-count":22,"title":["BARD1, a possible biomarker for breast and ovarian cancer"],"prefix":"10.1016","volume":"117","author":[{"given":"Irmgard","family":"Irminger-Finger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ygyno.2009.10.079_bib1","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1038\/sj.bjc.6603783","article-title":"Recent increase of breast cancer incidence among women under the age of forty","volume":"96","author":"Bouchardy","year":"2007","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2009.10.079_bib2","doi-asserted-by":"crossref","DOI":"10.1111\/j.1349-7006.2009.01147.x","article-title":"Cost-effective mammography screening in Korea: high incidence of breast cancer in young women","author":"Lee","year":"2009","journal-title":"Cancer Sci."},{"issue":"20","key":"10.1016\/j.ygyno.2009.10.079_bib3","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1001\/jama.270.20.2444","article-title":"Positive predictive value of screening mammography by age and family history of breast cancer","volume":"270","author":"Kerlikowske","year":"1993","journal-title":"Jama"},{"issue":"20","key":"10.1016\/j.ygyno.2009.10.079_bib4","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1056\/NEJMra0802968","article-title":"Inherited susceptibility to common cancers","volume":"359","author":"Foulkes","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.ygyno.2009.10.079_bib5","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa0900212","article-title":"Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers","volume":"361","author":"Fong","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ygyno.2009.10.079_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2007.03.014","article-title":"Cancer therapy: new drugs are emerging based on molecular targeting but still many challenges","author":"Altucci","year":"2007","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"2","key":"10.1016\/j.ygyno.2009.10.079_bib7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1159\/000123846","article-title":"The molecular pathology of hereditary breast cancer","volume":"75","author":"Palacios","year":"2008","journal-title":"Pathobiology"},{"issue":"7-8","key":"10.1016\/j.ygyno.2009.10.079_bib8","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.biocel.2007.04.015","article-title":"Molecular targeted therapies in breast cancer: where are we now?","volume":"39","author":"Widakowich","year":"2007","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"5927","key":"10.1016\/j.ygyno.2009.10.079_bib9","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1126\/science.1174839","article-title":"Cancer. Complicated supercomplexes","volume":"324","author":"Livingston","year":"2009","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.ygyno.2009.10.079_bib10","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/nrc1878","article-title":"Is there more to BARD1 than BRCA1?","volume":"6","author":"Irminger-Finger","year":"2006","journal-title":"Nat. Rev. Cancer"},{"issue":"1-4","key":"10.1016\/j.ygyno.2009.10.079_bib11","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1159\/000077512","article-title":"Possible causes of chromosome instability: comparison of chromosomal abnormalities in cancer cell lines with mutations in BRCA1, BRCA2, CHK2 and BUB1","volume":"104","author":"Grigorova","year":"2004","journal-title":"Cytogenet. Genome Res."},{"issue":"18","key":"10.1016\/j.ygyno.2009.10.079_bib12","doi-asserted-by":"crossref","first-page":"14537","DOI":"10.1074\/jbc.C000881200","article-title":"The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation","volume":"276","author":"Hashizume","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"26","key":"10.1016\/j.ygyno.2009.10.079_bib13","doi-asserted-by":"crossref","first-page":"24498","DOI":"10.1074\/jbc.M414020200","article-title":"BRCA1\/BARD1 ubiquitinate phosphorylated RNA polymerase II","volume":"280","author":"Starita","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"19","key":"10.1016\/j.ygyno.2009.10.079_bib14","doi-asserted-by":"crossref","first-page":"8457","DOI":"10.1128\/MCB.24.19.8457-8466.2004","article-title":"BRCA1-dependent ubiquitination of gamma-tubulin regulates centrosome number","volume":"24","author":"Starita","year":"2004","journal-title":"Mol. Cell. Biol."},{"issue":"10","key":"10.1016\/j.ygyno.2009.10.079_bib15","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1101\/gad.1309505","article-title":"BRCA1\/BARD1 inhibition of mRNA 3\u2032 processing involves targeted degradation of RNA polymerase II","volume":"19","author":"Kleiman","year":"2005","journal-title":"Genes Dev."},{"issue":"3","key":"10.1016\/j.ygyno.2009.10.079_bib16","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.cell.2006.08.053","article-title":"The BRCA1\/BARD1 heterodimer modulates ran-dependent mitotic spindle assembly","volume":"127","author":"Joukov","year":"2006","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.ygyno.2009.10.079_bib17","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0092-8674(00)80503-6","article-title":"Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage","volume":"90","author":"Scully","year":"1997","journal-title":"Cell"},{"issue":"21","key":"10.1016\/j.ygyno.2009.10.079_bib18","doi-asserted-by":"crossref","first-page":"9305","DOI":"10.1128\/MCB.24.21.9305-9316.2004","article-title":"Genetic steps of mammalian homologous repair with distinct mutagenic consequences","volume":"24","author":"Stark","year":"2004","journal-title":"Mol. Cell. Biol."},{"issue":"5697","key":"10.1016\/j.ygyno.2009.10.079_bib19","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1126\/science.1102574","article-title":"Abnormal cytokinesis in cells deficient in the breast cancer susceptibility protein BRCA2","volume":"306","author":"Daniels","year":"2004","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.ygyno.2009.10.079_bib20","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1158\/0008-5472.CAN-08-2134","article-title":"Distinct roles of BARD1 isoforms in mitosis: full length BARD1 mediates Aurora B degradation, cancer-associated BARD1? Scaffolds Aurora B and BRCA2","volume":"69","author":"Ryser","year":"2009","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.ygyno.2009.10.079_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1006189906896","article-title":"BRCA1 and BRCA2 in breast cancer","volume":"54","author":"Yang","year":"1999","journal-title":"Breast Cancer Res. Treat."},{"issue":"6","key":"10.1016\/j.ygyno.2009.10.079_bib22","first-page":"1425","article-title":"BARD1 content correlates with increased DNA fragmentation associated with muscle wasting in tumour-bearing rats","volume":"15","author":"Irminger-Finger","year":"2006","journal-title":"Oncol. Rep."},{"issue":"4","key":"10.1016\/j.ygyno.2009.10.079_bib23","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/ng1296-430","article-title":"Identification of a RING protein that can interact in vivo with the BRCA1 gene product","volume":"14","author":"Wu","year":"1996","journal-title":"Nat. Genet."},{"issue":"7","key":"10.1016\/j.ygyno.2009.10.079_bib24","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.1371\/journal.pmed.0030217","article-title":"The BARD1 Cys557Ser variant and breast cancer risk in Iceland","volume":"3","author":"Stacey","year":"2006","journal-title":"PLoS Med."},{"issue":"22","key":"10.1016\/j.ygyno.2009.10.079_bib25","doi-asserted-by":"crossref","first-page":"12983","DOI":"10.1073\/pnas.95.22.12983","article-title":"BRCA1 is associated with the centrosome during mitosis","volume":"95","author":"Hsu","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"24","key":"10.1016\/j.ygyno.2009.10.079_bib26","doi-asserted-by":"crossref","first-page":"11876","DOI":"10.1158\/0008-5472.CAN-07-2370","article-title":"Oncogenic BARD1 isoforms expressed in gynecological cancers","volume":"67","author":"Li","year":"2007","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.ygyno.2009.10.079_bib27","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/ijc.21428","article-title":"Aberrant expression of BARD1 in breast and ovarian cancers with poor prognosis","volume":"118","author":"Wu","year":"2006","journal-title":"Int. J. Cancer"},{"issue":"20","key":"10.1016\/j.ygyno.2009.10.079_bib28","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1038\/sj.onc.1207427","article-title":"Nuclear-cytoplasmic translocation of BARD1 is linked to its apoptotic activity","volume":"23","author":"Jefford","year":"2004","journal-title":"Oncogene"},{"issue":"23","key":"10.1016\/j.ygyno.2009.10.079_bib29","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1038\/sj.onc.1208491","article-title":"BARD1 induces apoptosis by catalysing phosphorylation of p53 by DNA-damage response kinase","volume":"24","author":"Feki","year":"2005","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.ygyno.2009.10.079_bib30","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.canlet.2005.03.012","article-title":"A truncated splice variant of human BARD1 that lacks the RING finger and ankyrin repeats","volume":"233","author":"Tsuzuki","year":"2006","journal-title":"Cancer Lett."},{"issue":"9","key":"10.1016\/j.ygyno.2009.10.079_bib31","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/j.biocel.2007.04.018","article-title":"Identification of BARD1 splice-isoforms involved in human trophoblast invasion","volume":"39","author":"Li","year":"2007","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ygyno.2009.10.079_bib32","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M702627200","article-title":"BARD1 translocation to mitochondria correlates with Bax oligomerization, loss of mitochondrial membrane potential and apoptosis","author":"Tembe","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.ygyno.2009.10.079_bib33","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/gcc.20460","article-title":"Identification of novel alternatively spliced BRCA1-associated RING domain (BARD1) messenger RNAs in human peripheral blood lymphocytes and in sporadic breast cancer tissues","volume":"46","author":"Lombardi","year":"2007","journal-title":"Genes Chromosomes Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2009.10.079_bib34","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/jhg.2009.6","article-title":"Genetic sequence variations of BRCA1-interacting genes AURKA, BAP1, BARD1 and DHX9 in French Canadian families with high risk of breast cancer","volume":"54","author":"Guenard","year":"2009","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.ygyno.2009.10.079_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/ng.374","article-title":"Common variations in BARD1 influence susceptibility to high-risk neuroblastoma","author":"Capasso","year":"2009","journal-title":"Nat. Genet."},{"issue":"1-2","key":"10.1016\/j.ygyno.2009.10.079_bib36","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.mce.2007.01.001","article-title":"Estrogen receptor alpha regulates expression of the breast cancer 1 associated ring domain 1 (BARD1) gene through intronic DNA sequence","volume":"267","author":"Creekmore","year":"2007","journal-title":"Mol. Cell. Endocrinol."},{"issue":"5","key":"10.1016\/j.ygyno.2009.10.079_bib37","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1158\/1078-0432.CCR-08-0640","article-title":"The complex relationship between BRCA1 and ERalpha in hereditary breast cancer","volume":"15","author":"Gorski","year":"2009","journal-title":"Clin. Cancer Res."},{"issue":"14","key":"10.1016\/j.ygyno.2009.10.079_bib38","doi-asserted-by":"crossref","first-page":"5794","DOI":"10.1073\/pnas.0610887104","article-title":"Estrogen receptor alpha is a putative substrate for the BRCA1 ubiquitin ligase","volume":"104","author":"Eakin","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ygyno.2009.10.079_bib39","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1752-0509-2-2","article-title":"Linking the ovarian cancer transcriptome and immunome","volume":"2","author":"Rapberger","year":"2008","journal-title":"BMC Syst. Biol."},{"issue":"9","key":"10.1016\/j.ygyno.2009.10.079_bib40","first-page":"680","article-title":"Clinical evaluation of autoantibody of splice variant of BARD1 in detection of ovarian cancer","volume":"43","author":"Yang","year":"2008","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"issue":"6","key":"10.1016\/j.ygyno.2009.10.079_bib41","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S1097-2765(01)00406-3","article-title":"Identification of BARD1 as mediator between proapoptotic stress and p53-dependent apoptosis","volume":"8","author":"Irminger-Finger","year":"2001","journal-title":"Mol. Cell"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825809009068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825809009068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,14]],"date-time":"2018-12-14T21:53:52Z","timestamp":1544824432000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825809009068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0090825809009068"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2009.10.079","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}